EA200001252A1 - COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON - Google Patents

COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON

Info

Publication number
EA200001252A1
EA200001252A1 EA200001252A EA200001252A EA200001252A1 EA 200001252 A1 EA200001252 A1 EA 200001252A1 EA 200001252 A EA200001252 A EA 200001252A EA 200001252 A EA200001252 A EA 200001252A EA 200001252 A1 EA200001252 A1 EA 200001252A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ifn
person
composition
recombinant interferon
interferon
Prior art date
Application number
EA200001252A
Other languages
Russian (ru)
Inventor
Джон Элам
Марк Родж
Сьюзан Гельц
Original Assignee
Байоджен, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байоджен, Инк. filed Critical Байоджен, Инк.
Publication of EA200001252A1 publication Critical patent/EA200001252A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Жидкие композиции, содержащие буфер с pH примерно 7,2, рекомбинантный β-интерферон и 15 мг/мл сывороточного альбумина человека, а также наборы для парентерального введения, включающие упомянутые композиции.Международная заявка была опубликована вместе с отчетом о международном поиске.Liquid compositions containing a buffer with a pH of about 7.2, recombinant β-interferon and 15 mg / ml of human serum albumin, as well as parenteral kits containing these compositions. The international application was published along with an international search report.

EA200001252A 1998-05-29 1998-05-29 COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON EA200001252A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
EA200001252A1 true EA200001252A1 (en) 2001-06-25

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001252A EA200001252A1 (en) 1998-05-29 1998-05-29 COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON

Country Status (16)

Country Link
EP (1) EP1082132A1 (en)
JP (1) JP2002516874A (en)
KR (1) KR20010052454A (en)
CN (1) CN1299285A (en)
AU (1) AU8822598A (en)
BR (1) BR9815966A (en)
CA (1) CA2333063A1 (en)
EA (1) EA200001252A1 (en)
EE (1) EE200000694A (en)
HU (1) HUP0102241A2 (en)
IL (1) IL139933A0 (en)
IS (1) IS5732A (en)
NO (1) NO20006022L (en)
SK (1) SK17762000A3 (en)
TR (1) TR200003521T2 (en)
WO (1) WO1999062542A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
DE60130145T2 (en) * 2000-12-21 2008-05-15 Resuscitation Technologies, LLC, Santa Monica STABLE T3 COMPOSITIONS AND ITS APPLICATION
CN1325651C (en) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 High-efficiency expression and application of human recombinant interferon B
CN1535724B (en) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 New application of recombinant human interferon for preventing serious acute respiratory tract syndrome
DK2868315T3 (en) * 2007-12-04 2017-09-04 Biogen Chesapeake Llc IMPROVED FORMULATIONS AND PROCEDURES FOR FREEZING DRYING AND THEREOF, LYOFILATES PREPARED
JP2023540800A (en) * 2020-09-12 2023-09-26 アカデミア シニカ Refolded human serum albumin and its antitumor use

Also Published As

Publication number Publication date
EE200000694A (en) 2002-06-17
SK17762000A3 (en) 2001-07-10
AU8822598A (en) 1999-12-20
NO20006022L (en) 2001-01-26
CA2333063A1 (en) 1999-12-09
WO1999062542A1 (en) 1999-12-09
CN1299285A (en) 2001-06-13
JP2002516874A (en) 2002-06-11
IL139933A0 (en) 2002-02-10
EP1082132A1 (en) 2001-03-14
KR20010052454A (en) 2001-06-25
IS5732A (en) 2000-11-24
HUP0102241A2 (en) 2001-10-28
BR9815966A (en) 2001-02-28
TR200003521T2 (en) 2001-07-23
NO20006022D0 (en) 2000-11-28

Similar Documents

Publication Publication Date Title
DE69807679D1 (en) COMPOSITIONS OF CONJUGATES OF THE STABLE, ACTIVE, HUMAN OB PROTEINS WITH THE FC CHAIN OF IMMUNOGLOBULINES AND RELATED PROCEDURES
PE20000560A1 (en) USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C
BR9811744A (en) Conjugates containing antenapedia homeodomain
FI932561A (en) Protein with intact epithelium and pharyngeal protein
NO995906L (en) Radioprotectant for peptides labeled with radioisotope
EA200000311A1 (en) NEW PROTEIN IMMUNE SYSTEM - KAU
ES2121479T3 (en) STABILIZING SOLUTION FOR PROTEINS AND PEPTIDES.
DE69931507D1 (en) INTERFERON-BETA FUSION PROTEINS AND ITS USES
LU91342I2 (en) Byetta-Exenatide
EA200001023A1 (en) SPECIFIC FOR FAPA- (PROTEIN ALPHA FIBROBE ACTIVATION) ANTIBODY WITH INCREASED PRODUCTIVITY
EA199901100A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE AND CAFFEINE
EE9800306A (en) Isolated dimeric fibroblast activation protein alpha and its uses
ATE125269T1 (en) RADIOM LABELED PEPTIDES WITH ANTICOAGULATE EFFECT.
JO2034B1 (en) LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
DK0523395T3 (en) Seroreactive regions on proteins E1 and E2 in HPV 16
PT935609E (en) CRYSTALLIZING COMPOSITIONS CONTAINING A COMPLEX BETWEEN THE PROTEASE NS3 DOMAIN OF HEPATITIS C VIRUS AND NS4A RESULTANT CRYSTALS
EA199901024A1 (en) PHARMACEUTICAL ANTI-VIRUS COMPOSITION CONTAINING GLYCIRRIZIN ACID AND, AT LEAST MEASURES, ONE PROTEIN OWNED BY ANTI-VIRUS ACTIVITY
EA200100264A1 (en) ANGIOCIDIN: AN ADHESIVE CELL TUMOR RECEPTOR SPECIFIC FOR CYS-SER-VAL-THR-CYS-GLY
EA199901113A1 (en) CARBOXAMIDES AS 5-HT1F AGONISTS
EA200001252A1 (en) COMPOSITION OF THE RECOMBINANT INTERFERON-β-1A (IFN-β-1A) PERSON
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
DE69529272D1 (en) MONOCLONAL ANTIBODY AGAINST THE HUMANE Mx-PROTEIN MxA
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
DK0939769T3 (en) The vertebrate Smoothened proteins
TR200000416T2 (en) Neisseria loctoferrin binding protein.